Clinical Trial Update: 0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating the efficacy and safety of 0.3% sodium hyaluronate for treating dry eye in patients with diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Dry Eye Disease

Drugs mentioned

• 0.3% sodium hyaluronate (sodium hyaluronate)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Dry Eye Syndromes, Diabetes Mellitus | Phase 4 | Status: UNKNOWN